|
|
||||||||
Clinical Chemistry, Vol 37, 1955-1967, Copyright © 1991 by American Association for Clinical Chemistry
RP Ekins and FW Chu
Department of Molecular Endocrinology, University College and Middlesex School of Medicine, London, U.K.
Throughout the 1970s, controversy centered both on immunoassay "sensitivity" per se and on the relative sensitivities of labeled antibody (Ab) and labeled analyte methods. Our theoretical studies revealed that RIA sensitivities could be surpassed only by the use of very high-specificity nonisotopic labels in "noncompetitive" designs, preferably with monoclonal antibodies. The time-resolved fluorescence methodology known as DELFIA--developed in collaboration with LKB/Wallac- -represented the first commercial "ultrasensitive" nonisotopic technique based on these theoretical insights, the same concepts being subsequently adopted in comparable methodologies relying on the use of chemiluminescent and enzyme labels. However, high-specific-activity labels also permit the development of "multianalyte" immunoassay systems combining ultrasensitivity with the simultaneous measurement of tens, hundreds, or thousands of analytes in a small biological sample. This possibility relies on simple, albeit hitherto-unexploited, physicochemical concepts. The first is that all immunoassays rely on the measurement of Ab occupancy by analyte. The second is that, provided the Ab concentration used is "vanishingly small," fractional Ab occupancy is independent of both Ab concentration and sample volume. This leads to the notion of "ratiometric" immunoassay, involving measurement of the ratio of signals (e.g., fluorescent signals) emitted by two labeled Abs, the first (a "sensor" Ab) deposited as a microspot on a solid support, the second (a "developing" Ab) directed against either occupied or unoccupied binding sites of the sensor Ab. Our preliminary studies of this approach have relied on a dual-channel scanning-laser confocal microscope, permitting microspots of area 100 microns 2 or less to be analyzed, and implying that an array of 10(6) Ab-containing microspots, each directed against a different analyte, could, in principle, be accommodated on an area of 1 cm2. Although measurement of such analyte numbers is unlikely ever to be required, the ability to analyze biological fluids for a wide spectrum of analystes is likely to transform immunodiagnostics in the next decade.
The following articles in journals at HighWire Press have cited this article:
![]() |
J. D. McBride, F. G. Gabriel, J. Fordham, T. Kolind, G. Barcenas-Morales, D. A. Isenberg, M. Swana, P. J. Delves, T. Lund, I. A. Cree, et al. Screening Autoantibody Profiles in Systemic Rheumatic Disease with a Diagnostic Protein Microarray That Uses a Filtration-Assisted Nanodot Array Luminometric Immunoassay (NALIA) Clin. Chem., May 1, 2008; 54(5): 883 - 890. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-a. Kwon, H. Lee, K. N. Lee, K. Chae, S. Lee, D.-k. Lee, and S. Kim High Diagnostic Accuracy of Antigen Microarray for Sensitive Detection of Hepatitis C Virus Infection Clin. Chem., February 1, 2008; 54(2): 424 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Dandy, P. Wu, and D. W. Grainger Array feature size influences nucleic acid surface capture in DNA microarrays PNAS, May 15, 2007; 104(20): 8223 - 8228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lakowicz, J. Malicka, E. Matveeva, I. Gryczynski, and Z. Gryczynski Plasmonic Technology: Novel Approach to Ultrasensitive Immunoassays Clin. Chem., October 1, 2005; 51(10): 1914 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Du, M. Wu, W. Yang, G. Yuan, Y. Sun, Y. Lu, S. Zhao, Q. Du, J. Wang, S. Yang, et al. Development of Miniaturized Competitive Immunoassays on a Protein Chip as a Screening Tool for Drugs Clin. Chem., February 1, 2005; 51(2): 368 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Saviranta, R. Okon, A. Brinker, M. Warashina, J. Eppinger, and B. H. Geierstanger Evaluating Sandwich Immunoassays in Microarray Format in Terms of the Ambient Analyte Regime Clin. Chem., October 1, 2004; 50(10): 1907 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Anderson and N. G. Anderson The Human Plasma Proteome: History, Character, and Diagnostic Prospects Mol. Cell. Proteomics, November 1, 2002; 1(11): 845 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arcellana-Panlilio and S. M. Robbins Cutting-edge technology: I. Global gene expression profiling using DNA microarrays Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G397 - G402. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wiese, Y. Belosludtsev, T. Powdrill, P. Thompson, and M. Hogan Simultaneous Multianalyte ELISA Performed on a Microarray Platform Clin. Chem., August 1, 2001; 47(8): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Soukka, J. Paukkunen, H. Harma, S. Lonnberg, H. Lindroos, and T. Lovgren Supersensitive Time-resolved Immunofluorometric Assay of Free Prostate-specific Antigen with Nanoparticle Label Technology Clin. Chem., July 1, 2001; 47(7): 1269 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eriksson, M. Vehniainen, T. Jansen, V. Meretoja, P. Saviranta, K. Pettersson, and T. Lovgren Dual-Label Time-resolved Immunofluorometric Assay of Free and Total Prostate-specific Antigen Based on Recombinant Fab Fragments Clin. Chem., May 1, 2000; 46(5): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Ostroff, D. Hopkins, A. B. Haeberli, W. Baouchi, and B. Polisky Thin Film Biosensor for Rapid Visual Detection of Nucleic Acid Targets Clin. Chem., September 1, 1999; 45(9): 1659 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Kricka Miniaturization of analytical systems Clin. Chem., September 1, 1998; 44(9): 2008 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Ekins Ligand assays: from electrophoresis to miniaturized microarrays Clin. Chem., September 1, 1998; 44(9): 2015 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Silzel, B. Cercek, C. Dodson, T. Tsay, and R. J. Obremski Mass-sensing, multianalyte microarray immunoassay with imaging detection Clin. Chem., September 1, 1998; 44(9): 2036 - 2043. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lovgren, P. Heinonen, P. Lehtinen, H. Hakala, J. Heinola, R. Harju, H. Takalo, V.-M. Mukkala, R. Schmid, H. Lonnberg, et al. Sensitive bioaffinity assays with individual microparticles and time-resolved fluorometry Clin. Chem., October 1, 1997; 43(10): 1937 - 1943. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |